2-U.S. FDA advisers weigh Moderna COVID vaccine heart risk for young men – Yahoo News
The U.S. Food and Drug Administration said Moderna’s COVID-19 vaccine may have a higher risk of heart inflammation in young men than the Pfizer/BioNTech shot, but the risk is relatively rare and most people who suffer the side effect fully recover.
Data from a U.S. Centers for Disease Control and Prevention database showed that 4.41 out of 100,000 people received the Pfizer/BioNTech shot, compared to 6.27 out of 100,000 people who received the Moderna shot. There have long been concerns that the Moderna shot may cause heart inflammation at higher rates.
Some countries in Europe have limited use of Moderna‘s vaccine for younger age groups after surveillance suggested it was tied to a higher risk of heart inflammation, and the FDA delayed its review of the Moderna shot to assess the myocarditis risk.
The FDA said data from European and Canadian regulators showed that the risk was 1.7 to 7.3 times higher for Moderna‘s vaccine than Pfizer‘s in adolescents and young men.
Long-term hangover effects of all the vaccines have not been extensively studied.
- UPDATE 2-U.S. FDA advisers weigh Moderna COVID vaccine heart risk for young men Yahoo News
- Moderna COVID vaccine may pose higher heart inflammation risk – US CDC msnNOW
- U.S. FDA advisers weigh Moderna COVID vaccine heart risk for young men Reuters
- More Post-Vaccination Heart Inflammation Among Young Males After COVID Booster: CDC The Epoch Times
- Moderna COVID shot linked to higher heart inflammation risk – CDC (NASDAQ:MRNA) Seeking Alpha
- View Full Coverage on Google News